Premium
FINAL ANALYSIS OF A NORDIC LYMPHOMA GROUP PHASE IB/IIA TRIAL OF PIXANTRONE, ETOPOSIDE, BENDAMUSTINE AND, IN CD20‐POSITIVE TUMORS, RITUXIMAB IN RELAPSED AGGRESSIVE B‐ OR T‐CELL LYMPHOMAS
Author(s) -
d'Amore F,
Leppä S,
Relander T,
Larsen T. S,
Brown P,
Jørgensen J,
Mannisto S,
Lugtenburg P,
Leivonen S.K,
Holte H,
Fagerli U. M,
Lauritzsen G. F,
Meyer P,
Minotti G,
Menna P,
Liestøl K,
Toldbod H
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.151_2880
Subject(s) - medicine , neutropenia , bendamustine , febrile neutropenia , gastroenterology , rituximab , regimen , phases of clinical research , lymphoma , surgery , clinical trial , chemotherapy